乐观
$46.65
情景价格
$37.450
-0.551 (-1.47%)收盘时
Astrana Health, Inc. is a physician-centric, artificial intelligence (AI)-powered healthcare company focused on delivering patient-centered care. The Company provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company's segments include Care Partners, Care Delivery, and Care Enablement. Its Care Partners segment is focused on building and managing provider networks by partnering with, empowering, and investing in provider partners aligned on a shared vision for coordinated care delivery. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. Its Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information. It supports more than 20,000 providers.
Astrana Health Inc is a good buy right now due to its strong revenue growth of 55.4% over the past two years and a forward P/E ratio of 8.97, indicating potential for significant upside. The current price of $37.45 is well below the average analyst price target of $53, suggesting a substantial upside potential of 41.7%. However, there is a risk of a recent data breach that caused a 6% drop in stock price, which investors should monitor closely.
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

Verda Healthcare Partners with AstranaCare to Enhance Healthcare Access

Astrana Health to Release Q3 Financial Results on November 5, 2026

McDonald's CEO Warns of Inflation Impact on Sales

Two Stocks to Watch Under $50 and One to Sell

Key Highlights from Astrana Health's Q2 Earnings Call
Astrana Health, Inc. is a physician-centric, artificial intelligence (AI)-powered healthcare company focused on delivering patient-centered care. The Company provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company's segments include Care Partners, Care Delivery, and Care Enablement. Its Care Partners segment is focused on building and managing provider networks by partnering with, empowering, and investing in provider partners aligned on a shared vision for coordinated care delivery. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. Its Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information. It supports more than 20,000 providers. It operates in the Healthcare sector (MANAGEMENT CONSULTING SERVICES industry).
Astrana Health Inc is a good buy right now due to its strong revenue growth of 55.4% over the past two years and a forward P/E ratio of 8.97, indicating potential for significant upside. The current price of $37.45 is well below the average analyst price target of $53, suggesting a substantial upside potential of 41.7%. However, there is a risk of a recent data breach that caused a 6% drop in stock price, which investors should monitor closely.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。